Alkomas, UAB - financials and debts

Company age: 12 y. 1 mo.

Update

Alkomas - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 4,910 22,880 7,845 10,945 11,686 11,891 13,125 12,300
Profit before tax - - - - - - - -
Net profit 3,581 19,849 934 -7,094 -10,613 2,760 209 -1,692
Equity 23,491 42,218 40,871 33,777 23,164 25,924 26,133 24,441
Liabilities 57,264 69,059 35,905 12,665 15,521 13,434 9,700 13,307
Non-current assets 14,643 40,143 35,185 32,265 31,879 27,128 23,907 20,686
Current assets 66,112 71,134 41,591 14,177 6,806 12,230 11,926 16,982
Total assets 80,755 111,277 76,776 46,442 38,685 39,358 35,833 37,668
Taxes paid
STI taxes - - - - - 396 1,989 925
Financial indicators
Revenue change y/y -78.7% +366.0% -65.7% +39.5% +6.8% +1.8% +10.4% -6.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 4.4% 17.8% 1.2% -15.3% -27.4% 7.0% 0.6% -4.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 15.2% 47.0% 2.3% -21.0% -45.8% 10.6% 0.8% -6.9%
Profit margin Net profit margin. Shows the overall profitability of the company. 72.9% 86.8% 11.9% -64.8% -90.8% 23.2% 1.6% -13.8%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - - - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 2.4 1.6 0.9 0.4 0.7 0.5 0.4 0.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 4,910 22,880 7,845 10,945 11,686 11,891 13,125 12,300

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Alkomas - Social security debts

The amount of overdue SODRA debt for the company Alkomas as of the last working day is: 13 €

From To Debt, €
2026-09-05 2026-09-13 12.78
2026-08-26 2026-09-02 12.78
2026-08-23 2026-08-23 12.78
2026-08-19 2026-08-19 12.78
2026-08-16 2026-08-17 8.53
2026-07-28 2026-08-14 8.53
2026-07-26 2026-07-27 8.50
2026-07-23 2026-07-25 8.53
2026-07-19 2026-07-22 8.50
2026-07-16 2026-07-17 8.50
2026-06-16 2026-07-15 4.25
2025-10-23 2025-11-13 0.02
2025-07-28 2025-08-03 4.30
2025-07-26 2025-07-27 4.25
2025-07-24 2025-07-25 4.30
2025-06-17 2025-07-23 4.25
2025-05-16 2025-05-29 4.25
2024-10-24 2024-11-14 0.04
2024-07-16 2024-08-13 4.25
2024-01-23 2024-02-14 0.01
2023-10-26 2023-10-26 4.25
2023-10-24 2023-10-25 4.58
2023-10-17 2023-10-23 4.25
2023-09-18 2023-09-26 21.56
2023-08-17 2023-09-17 17.31
2023-07-24 2023-08-16 13.06
2023-07-18 2023-07-23 12.93
2023-06-16 2023-07-17 8.68
2023-05-16 2023-06-15 4.43
2023-05-02 2023-05-15 0.18
2023-04-25 2023-04-28 0.18
2023-04-18 2023-04-23 4.25
2023-02-17 2023-03-15 12.85
2023-02-06 2023-02-16 8.60
2023-01-23 2023-02-03 8.60
2023-01-17 2023-01-22 8.50
2022-12-16 2023-01-16 4.25
2022-11-21 2022-11-21 8.62
2022-11-17 2022-11-18 8.62
2022-10-28 2022-11-16 4.37
2022-10-18 2022-10-27 4.25
2022-09-16 2022-09-25 4.25
2022-08-26 2022-08-29 12.75
2022-08-23 2022-08-25 12.87
2022-07-25 2022-08-22 8.62
2022-07-18 2022-07-24 8.50
2022-06-16 2022-07-17 4.25
2022-04-25 2022-05-12 8.55
2022-04-19 2022-04-24 8.50
2022-03-16 2022-04-18 4.25
2022-02-17 2022-02-24 4.27
2022-01-18 2022-02-16 0.02
2021-12-16 2022-01-16 0.02

Alkomas - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Alkomas, UAB (code 303382145) is a Private Limited Liability Company operating in beauty care and other beauty treatment activities. In 2025, the company generated revenue of €12.3K, down 6.3% year on year, while net profit turned negative at €1.7K, compared with a small profit of €209 in 2024. This followed a stronger 2023 result, when revenue was €11.9K and net profit reached €2.8K. Over the three-year period, revenue increased modestly overall by 3.4% versus 2023, but profitability weakened sharply in 2025, with a profit margin of -13.8%. Return on equity was -6.9% and return on assets was -4.5%, reflecting the loss in the latest year. At the end of 2025, total assets were €37.7K, equity €24.4K and liabilities €13.3K, giving an equity ratio of 64.9% and debt-to-equity of 0.54. Asset turnover stood at 0.33x. Revenue per employee was €12.3K, while profit per employee was -€1.7K.